Home > Boards > US Listed > Medical - Drugs > Allergan (AGN)

2Q19 worldwide Botox sales=$974.0M, +4% YoY, +12% QoQ*:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 728
Posts 110,858
Boards Moderated 15
Alias Born 09/05/02
160x600 placeholder
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 2/19/2020 10:50:00 AM
Form 8.3 - Abbvie Inc Dow Jones News - 2/19/2020 9:43:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 2/18/2020 4:32:14 PM
Form 8.3 - [ AbbVie Inc.] Dow Jones News - 2/18/2020 9:51:00 AM
Form 8.3 - [Abbvie. Inc] Dow Jones News - 2/17/2020 9:12:00 AM
Announcement under the Irish Takeover Rules: Relevant Securities in Issue - February 14, 2020 PR Newswire (US) - 2/14/2020 4:15:00 PM
Form 8.3 - [Abbvie. Inc] Dow Jones News - 2/14/2020 9:23:00 AM
Announcement under Rule 8.1(a) of the Irish Takeover Rules: Dealings by Offerors, Offerees or Parties Acting in Concert With ... PR Newswire (US) - 2/14/2020 7:00:00 AM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 2/13/2020 5:14:08 PM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 2/13/2020 10:50:00 AM
Form 8.3 - [Abbvie. Inc] Dow Jones News - 2/13/2020 9:56:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 11:04:08 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 2/12/2020 10:50:00 AM
Form 8.3 - [Abbvie. Inc] Dow Jones News - 2/12/2020 10:01:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 2/11/2020 10:50:00 AM
Form 8.3 -AbbVie Inc. Dow Jones News - 2/11/2020 9:54:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 2/10/2020 10:50:00 AM
Form 8.3 - Abbvie Inc Dow Jones News - 2/10/2020 10:06:00 AM
Allergan Tops 4Q Forecasts For Revenue, Adjusted Profit Dow Jones News - 2/10/2020 7:46:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/10/2020 7:36:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/10/2020 7:26:04 AM
Allergan Reports Fourth Quarter and Full-Year 2019 Financial Results PR Newswire (US) - 2/10/2020 7:00:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 2/7/2020 10:50:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 2/7/2020 9:26:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 2/6/2020 9:40:00 AM
DewDiligence Member Level  Tuesday, 08/06/19 07:58:18 AM
Re: DewDiligence post# 181
Post # of 198 
2Q19 worldwide Botox sales=$974.0M, +4% YoY, +12% QoQ*:

https://www.allergan.com/News/News/Thomson-Reuters/Allergan-Reports-Second-Quarter-2019-Financial-Res

• US therapeutic: $447.0M (+6% YoY, +12% QoQ)
• US cosmetic: $252.4M (+7% YoY, +10% QoQ)
--
US total: $699.4M (64% therapeutic; 36% cosmetic)


• Ex-US therapeutic: $98.8M (+1% YoY [constant currency], +5% QoQ)
• Ex-US cosmetic: $175.8M (+11% YoY [constant currency], +19% QoQ)
--
Ex-US total: $274.6M (36% therapeutic; 64% cosmetic)


*Botox sales are seasonally stronger in the second and fourth calendar quarters than in the first and third quarters.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist